Emergent adds new space for biotech start-ups
Emergent Technologies (ETI) has doubled its office space, taking new digs in Austin that includes new laboratory space for the biotech companies that it helps foster. ETI specializes in creating new companies that are engaged in commercializing research pioneered at regional universities.
Thomas Harlan, president and CEO of ETI, told the Austin Business Journal that the company had just run out of room. ETI moved from 12,000 square feet into 23,000 square feet of space. ETI closed a $27 million fund in the spring of 2007 and used the money to launch three companies: Mimetic Solutions, Beacon Sciences and AeonClad Coatings.
"The biotech sector is a limitless one," Harlan told the newspaper. "We're delighted to be sitting in a region where there's abundant deal flow, in terms of the science coming from the university."
- read the report in the Austin Business Journal
Related Articles:
Emergent BioSolutions buys flu vaccine maker
Emergent BioSolutions files $86M IPO
Comments
Post new comment
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets


